- Home
- STOK vs SMBC Comparison
STOK vs SMBC Comparison
Compare STOK & SMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- SMBC
- Stock Information
- Founded
- STOK 2014
- SMBC 1887
- Country
- STOK United States
- SMBC United States
- Employees
- STOK N/A
- SMBC N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- SMBC Banks
- Sector
- STOK Health Care
- SMBC Finance
- Exchange
- STOK Nasdaq
- SMBC Nasdaq
- Market Cap
- STOK 556.7M
- SMBC 666.1M
- IPO Year
- STOK 2019
- SMBC N/A
- Fundamental
- Price
- STOK $8.33
- SMBC $58.66
- Analyst Decision
- STOK Strong Buy
- SMBC Buy
- Analyst Count
- STOK 8
- SMBC 3
- Target Price
- STOK $23.83
- SMBC $70.00
- AVG Volume (30 Days)
- STOK 830.1K
- SMBC 32.8K
- Earning Date
- STOK 03-24-2025
- SMBC 01-27-2025
- Dividend Yield
- STOK N/A
- SMBC 1.57%
- EPS Growth
- STOK N/A
- SMBC 19.21
- EPS
- STOK N/A
- SMBC 4.59
- Revenue
- STOK $16,742,999.00
- SMBC $166,907,000.00
- Revenue This Year
- STOK $105.42
- SMBC N/A
- Revenue Next Year
- STOK $15.13
- SMBC $6.98
- P/E Ratio
- STOK N/A
- SMBC $12.78
- Revenue Growth
- STOK 81.08
- SMBC 8.43
- 52 Week Low
- STOK $5.28
- SMBC $39.00
- 52 Week High
- STOK $17.58
- SMBC $68.69
- Technical
- Relative Strength Index (RSI)
- STOK 32.00
- SMBC 47.14
- Support Level
- STOK $9.76
- SMBC $58.75
- Resistance Level
- STOK $11.11
- SMBC $61.21
- Average True Range (ATR)
- STOK 0.88
- SMBC 1.44
- MACD
- STOK -0.30
- SMBC -0.02
- Stochastic Oscillator
- STOK 2.31
- SMBC 31.75
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About SMBC Southern Missouri Bancorp Inc.
Southern Missouri Bancorp Inc is a us-based holding company for Southern Missouri Savings Bank. The principal business of the bank consists of attracting retail deposits from the general public and using such deposits along with wholesale funding from the Federal Home Loan Bank of Des Moines, and to a lesser extent, brokered deposits, to invest in one- to four-family residential mortgage loans, mortgage loans secured by commercial real estate, commercial non-mortgage business loans, and consumer loans. It is engaged in providing the range of banking and financial services to individuals and corporate customers in its market areas. The company derives revenue principally from interest earned on loans, debt securities, bank card interchange fees, loan late charges and another fee income.